Kirsten Harting
Directeur Technique/Scientifique/R&D chez ALZINOVA AB
Profil
Kirsten Harting is currently the Chief Medical Officer at Alzinova AB, SynAct Pharma AB, Tetra Pharm Technologies ApS, and Sandoz Group AG.
She previously worked as the Senior Director-Medical at CytoKi Pharma.
ApS.
Dr. Harting holds an MBA from Copenhagen Business School and a doctorate from the University of Copenhagen.
Postes actifs de Kirsten Harting
| Sociétés | Poste | Début |
|---|---|---|
| ALZINOVA AB | Directeur Technique/Scientifique/R&D | 14/08/2023 |
| SANDOZ GROUP AG | Directeur Technique/Scientifique/R&D | - |
| SYNACT PHARMA AB | Directeur Technique/Scientifique/R&D | 15/02/2024 |
Tetra Pharm Technologies ApS
 Tetra Pharm Technologies ApS Pharmaceuticals: MajorHealth Technology Tetra Pharm Technologies ApS designs and develops new drug formulations, conducts clinical trials, and commercializes medicines. The company is based in Hillerod, Denmark. The CEOs are Jesper Breum Kanchanarat and Martin Stefan Rose. The Danish company was founded in 2019. | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Kirsten Harting
| Sociétés | Poste | Fin |
|---|---|---|
CytoKi Pharma ApS
 CytoKi Pharma ApS Miscellaneous Commercial ServicesCommercial Services CytoKi Pharma ApS engages in the research and experimental development within biotechnology. It develops therapeutics for serious tissue and organ injuries. The company was founded by Rasmus Jørgensen on June 12, 2019 and is headquartered in Vaerlose, Denmark. | Directeur Technique/Scientifique/R&D | - |
Formation de Kirsten Harting
| Copenhagen Business School | Masters Business Admin |
| University of Copenhagen | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| SYNACT PHARMA AB | Health Technology |
| SANDOZ GROUP AG | Health Technology |
| ALZINOVA AB | Health Technology |
| Entreprise privées | 2 |
|---|---|
CytoKi Pharma ApS
CytoKi Pharma ApS Miscellaneous Commercial ServicesCommercial Services CytoKi Pharma ApS engages in the research and experimental development within biotechnology. It develops therapeutics for serious tissue and organ injuries. The company was founded by Rasmus Jørgensen on June 12, 2019 and is headquartered in Vaerlose, Denmark. | Commercial Services |
Tetra Pharm Technologies ApS
Tetra Pharm Technologies ApS Pharmaceuticals: MajorHealth Technology Tetra Pharm Technologies ApS designs and develops new drug formulations, conducts clinical trials, and commercializes medicines. The company is based in Hillerod, Denmark. The CEOs are Jesper Breum Kanchanarat and Martin Stefan Rose. The Danish company was founded in 2019. | Health Technology |
